Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in NERV — Minerva Neurosciences, Inc.

CIK 73124 CHICAGO, IL
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,621,248
+$1,059,068 QoQ
Shares Held
292,117
+213.1% QoQ
Ownership
0.612%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 58 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 98% Shared 2% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. NERV ranks #244 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in NERV

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,621,248 292,117
2026-03-31 $562,180 93,308
2024-12-31 $81,942 36,878
2024-09-30 $61,539 23,049
2024-06-30 $73,525 23,049
2024-03-31 $59,560 23,086
2023-12-31 $153,662 24,986
2022-03-31 $54,409 65,555
2021-12-31 $54,544 68,097
2021-09-30 $118,488 68,097
2021-06-30 $157,984 68,097
2021-03-31 $1,075,335 368,266
2020-12-31 $913,703 390,472
2020-09-30 $1,208,126 379,914
2020-06-30 $1,208,930 334,884
2020-03-31 $2,252,641 374,193